These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36332348)

  • 1. Outcomes after implementing a heart failure diuretic pathway in an emergency department setting.
    Bogner S; Bena JF; Morrison SL; Albert NM
    Heart Lung; 2023; 57():250-256. PubMed ID: 36332348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aggressive Versus Conservative Initial Diuretic Dosing in the Emergency Department for Acute Decompensated Heart Failure.
    Catlin JR; Adams CB; Louie DJ; Wilson MD; Louie EN
    Ann Pharmacother; 2018 Jan; 52(1):26-31. PubMed ID: 28786295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loop Diuretic Prescription and 30-Day Outcomes in Older Patients With Heart Failure.
    Faselis C; Arundel C; Patel S; Lam PH; Gottlieb SS; Zile MR; Deedwania P; Filippatos G; Sheriff HM; Zeng Q; Morgan CJ; Wopperer S; Nguyen T; Allman RM; Fonarow GC; Ahmed A
    J Am Coll Cardiol; 2020 Aug; 76(6):669-679. PubMed ID: 32762901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
    DeVore AD; Hasselblad V; Mentz RJ; O'Connor CM; Armstrong PW; McMurray JJ; Ezekowitz JA; Tang WH; Starling RC; Voors AA; Califf RM; Hernandez AF
    Eur J Heart Fail; 2015 Mar; 17(3):340-6. PubMed ID: 25619549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial.
    Mecklai A; Subačius H; Konstam MA; Gheorghiade M; Butler J; Ambrosy AP; Katz SD
    JACC Heart Fail; 2016 Jul; 4(7):580-588. PubMed ID: 27039131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.
    Woodruff AE; Kelley AM; Hempel CA; Loeffler WJ; Echtenkamp CA; Hassan AK
    Ann Pharmacother; 2016 Jun; 50(6):437-45. PubMed ID: 26956954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is adherence to weight monitoring or weight-based diuretic self-adjustment associated with fewer heart failure-related emergency department visits or hospitalizations?
    Jones CD; Holmes GM; Dewalt DA; Erman B; Broucksou K; Hawk V; Cene CW; Wu JR; Pignone M
    J Card Fail; 2012 Jul; 18(7):576-84. PubMed ID: 22748492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Ambulatory, High-Dose, Intravenous Diuretic Therapy to Standard Hospitalization and Diuretic Therapy for Treatment of Acute Decompensated Heart Failure.
    Buckley LF; Seoane-Vazquez E; Cheng JW; Aldemerdash A; Cooper IM; Matta L; Medina DS; Mehra MR; Navarro-Velez K; Shea EL; Weintraub JR; Stevenson LW; Desai AS
    Am J Cardiol; 2016 Nov; 118(9):1350-1355. PubMed ID: 27772698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuresis-guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium-based treatment algoritHm in Acute Heart Failure (PUSH-AHF) trial.
    Ter Maaten JM; Beldhuis IE; van der Meer P; Krikken JA; Coster JE; Nieuwland W; van Veldhuisen DJ; Voors AA; Damman K
    Eur J Heart Fail; 2022 Feb; 24(2):385-392. PubMed ID: 34791756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure.
    Aziz EF; Kukin M; Javed F; Pratap B; Sabharwal MS; Tormey D; Frankenberger O; Herzog E
    Hosp Pract (1995); 2011 Feb; 39(1):126-32. PubMed ID: 21441767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-Hospital Therapy for Heart Failure With Reduced Ejection Fraction in the United States.
    Greene SJ; Triana TS; Ionescu-Ittu R; Burne RM; Guérin A; Borentain M; Kessler PD; Tugcu A; DeSouza MM; Felker GM; Chen L
    JACC Heart Fail; 2020 Nov; 8(11):943-953. PubMed ID: 32800512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-diuretic spot urine sodium assessment in acute heart failure: a retrospective analysis.
    Colson L; Vanhentenrijk S; Kalpakos T; Roosens B; Von Kemp B; Balthazar T; Lochy S; Verbrugge FH
    Acta Clin Belg; 2024 Apr; 79(2):103-112. PubMed ID: 38613319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction.
    Coiro S; Girerd N; McMurray JJV; Pitt B; Swedberg K; van Veldhuisen DJ; Lamiral Z; Rossignol P; Zannad F
    Clin Res Cardiol; 2021 Aug; 110(8):1308-1320. PubMed ID: 33956209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diuretic Treatment in Patients with Heart Failure: Current Evidence and Future Directions - Part I: Loop Diuretics.
    Cuthbert JJ; Clark AL
    Curr Heart Fail Rep; 2024 Apr; 21(2):101-114. PubMed ID: 38240883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
    Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
    JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Diuretic-Sparing Effects of Sacubitril-Valsartan: Staying in the Loop.
    Orvin NJ; Beavers JC; Russell SD
    J Pharm Pract; 2022 Dec; 35(6):859-863. PubMed ID: 33882753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis.
    Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM
    J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between changes in loop diuretic dose and outcomes in acute heart failure.
    Seko Y; Kato T; Morimoto T; Yaku H; Inuzuka Y; Tamaki Y; Ozasa N; Shiba M; Yamamoto E; Yoshikawa Y; Yamashita Y; Kitai T; Taniguchi R; Iguchi M; Nagao K; Kawai T; Komasa A; Nishikawa R; Kawase Y; Morinaga T; Toyofuku M; Furukawa Y; Ando K; Kadota K; Sato Y; Kuwahara K; Kimura T;
    ESC Heart Fail; 2023 Jun; 10(3):1757-1770. PubMed ID: 36858382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Discharged Loop Diuretic Dose to Home Dose on Hospital Readmissions in Patients with Acute Decompensated Heart Failure: A Retrospective Cohort Study.
    Alshibani M; Alshehri S; Alyazidi W; Alnomani A; Almatruk Z; Almeleebia T
    Heart Surg Forum; 2020 Jul; 23(4):E470-E474. PubMed ID: 32726210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.